HPV e o câncer de orofaringe
DOI:
https://doi.org/10.11606/issn.2357-8041.clrd.2021.184527Palavras-chave:
Neoplasias orofaríngeas, HPV, Oncologia médicaResumo
Objetivo: O objetivo deste artigo é revisar a produção científica internacional e nacional sobre o HPV e o câncer de cabeça e pescoço, com foco nos tumores de orofaringe. Materiais e Métodos: Trata-se de uma revisão sistemática de literatura, em que foi realizada uma busca bibliográfica por meio de recursos eletrônicos obtidos, em sua maioria, na base de dados PubMed, publicados entre o período de 1999 a 2019. Resultados: É possível afirmar que o HPV é um fator para a formação câncer de células espinocelulares da orofaringe(CCEO) e, entre os tipos de HPV, o HPV-16 é o tipo mais comum relacionado ao SCCOP. Conclusões: Tendo em vista o alto índice de morbidade e a alta taxa de pacientes que possuem o diagnóstico de câncer de cabeça e pescoço tardio, deve- -se levar em consideração que o diagnóstico precoce é de suma importância para estes pacientes.
Downloads
Referências
Lewis A, Kang R, Levine A, Maghami E. The New Face of Head and Neck Cancer: The HPV Epidemic. Oncology (Williston Park). 2015;29(9):616-26.
Instituto Nacional do Câncer (BR). Homepage [Internet]. Rio de Janeiro: INCA; 2009 [citado em 15 maio 2018]. Disponível em: www.inca.gov.br
Albano PM, Holzinger D, Salvador C, Orosa J 3rd, Racelis S, Leaño M, Sanches D Jr, et al. Low prevalence of human papilloma virus in head and neck squamous cell carcinoma in the north west region of the Philippines. PLoSOne. 2017;12(2):e0172240. doi: https://doi.org/10.1371/journal.pone.0172240.
Mehanna H, Paleri V, West C, Nutting C. Head and neck cancer – Part 1: Epidemiology, presentation, and prevention. BMJ. 2010;341:c4684. doi: https://doi.org/10.1136/bmj.c4684.
Warnakulasuriya S. Global epidemiology of oral and oropharyngeal cancer. Oral Oncol. 2009;45(4-5):309-16. doi: https://doi.org/10.1016/j.oraloncology.2008.06.002.
Siegel R, Naishadham D, Jemal A. Cancer Statistics, 2012. CA Cancer J Clin. 2012;62(1):10-29. doi: https://doi.org/10.3322/caac.20138t.
Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61(2):69-90. doi: https://doi.org/10.3322/caac.20107.
Chaturvedi AK, Engels EA, Anderson WF, Gillison ML. Incidence trends for human papillomavirus-related and -unrelated oral squamous cell carcinomas in the United States. J Clin Oncol. 2008;26(4):612-9. doi: https://doi.org/10.1200/JCO.2007.14.1713.
Viens LJ, Henley SJ, Watson M, Markowitz LE, Thomas CC, Thompson TD, et al. Human papilomavirus: associated cancers: United States, 2008-2012. MMWR Morb Mortal Wkly Rep. 2016;65(26):661-6. doi: https://doi.org/10.15585/mmwr.mm6526a1.
Wirth L, Burtness B, Nathan CA, Grégoire V, Richmon J. Point/Counterpoint: Do We De-escalate Treatment of HPV-Associated Oropharynx Cancer Now? And How? Am Soc Clin Oncol Educ Book. 2019;39:364-72. doi: https://doi.org/10.1200/EDBK_238315.
IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Biological agents: Volume 100B: A review of human carcinogens. IARC Monogr Eval Carcinog Risks Hum. 2012;100(Pt B):1-441.
Bedell SL, Goldstein LS, Goldstein AR, Goldstein AT. Cervical Cancer Screening: past, present, and future. Sex Med Rev. 2020;8(1):28-37 doi: https://doi.org/10.1016/j.sxmr.2019.09.005.
Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol. 1999;189(1):12-9. doi: https://onlinelibrary.wiley.com/doi/10.1002/(SICI)1096-9896(199909)189:1%3C12::AID-PATH431%3E3.0.CO;2-F
Martel C, Plummer M, Vignat J, Franceschi S. Worldwide burden of cancer attributable to HPV by site, country and HPV type. Int J Cancer. 2017;141(4):664-70. doi: https://doi.org/10.1002/ijc.30716.
Berman TA, Schiller JT. Human papillomavirus in cervical cancer and oropharyngeal cancer: One cause, two diseases. Cancer. 2017;123(12):2219-29. doi: https://doi.org/10.1002/cncr.30588.
Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Matthers C, Rebelo M, et al. GLOBOCAN 2012: Estimated Cancer Incidence, Mortality and Prevalence Worldwide in 2012 v1.0. Lyon: IARC; 2013.
D’Souza G, Cullen K, Bowie J, Thorpe R, Fakhry C. Differences in oral sexual behaviors by gender, age, and race explain observed differences in prevalence of oral human papillomavirus infection. PLoSOne. 2014;9(1):19-21. doi: https://doi.org/10.1371/journal.pone.0086023.
Gao G, Smith DI. Human Papillomavirus and the Development of Different Cancers. Cytogenet Genome Res. 2016; 150(3-4):185-93. doi: https://doi.org/10.1159/000458166.
Taberna M, Inglehart RC, Pickard RK, Fakhry C, Agrawal A, Kats ML, et al. Significant changes in sexual behavior after a diagnosis of human papillomavirus-positive and human papillomavirus-negative oral cancer. Cancer. 2017;123(7):1156-65. doi: https://doi.org/10.1002/cncr.30564.
Combes JD, Chen AA, Franceschi S. Prevalence of human papillomavirus in cancer of the oropharynx by gender. Cancer Epidemiol Biomarkers Prev. 2014;23(12):2954-8. doi: https://doi.org/10.1158/1055-9965.EPI-14-0580.
Li H, Torabi SJ, Yarbrough WG, Mehra S, Osborn HA, Judson B. Association of Human Papillomavirus Status at Head and Neck Carcinoma Subsites With Overall Survival. JAMA Otolaryngol Head Neck Surg. 2018;144(6):519-525. doi: https://doi.org/10.1001/jamaoto.2018.0395.
Saunders CL, Meads C, Abel GA, Lyratzopoulos G. Associations Between Sexual Orientation and Overall and Site-Specific Diagnosis of Cancer: Evidence From Two National Patient Surveys in England. J Clin Oncol. 2017;35(32):3654-61. doi: https://doi.org/10.1200/JCO.2017.72.5465.
Gillison ML, Castellsagué X, Chaturvedi A, Goodman MT, Snijders P, Tommasino M, et al. Eurogin Roadmap: comparative epidemiology of HPV infection and associated cancers of the head and neck and cervix. Int J Cancer. 2014;134(3):497-507. doi: https://doi.org/10.1002/ijc.28201.
Organización Panamericana de la Salud. Classificación estadística internacional de enfermedades y problemas relacionados con la salud: décima revisión. Washington, DC: OPS; 1995.
Agalliu I, Gapstur S, Chen Z, Wang T, Anderson RL, Teras L, et al. Associations of Oral α-, β-, and γ-Human papillomavirus types with risk of incident head and neck cancer. JAMA Oncol. 2016;2(5):599-606. doi: https://doi.org/10.1001/jamaoncol.2015.5504.
Benson E, Li R, Eisele D, Fakhry C. The clinical impact of HPV tumor status upon head and neck squamous cell carcinomas. Oral Oncol. 2014;50(6):565-74. doi: https://doi.org/10.1016/j.oraloncology.2013.09.008.
Fakhry C, Westra WH, Wang SJ, van Zante A, Zhang Y, Rettig E, et al. The prognostic role of sex, race, and human papillomavirus in oropharyngeal and nonoropharyngeal head and neck squamous cell cancer. Cancer. 2017;123(9):1566-75. doi: https://doi.org/10.1002/cncr.30353.
Reuschenbach M, Wagner S, Würdemann N, Sharma SJ, Prigge ES, Sauer M, et al. Human papillomavirus and squamous cell cancer of the head and neck region: Prognostic, therapeutic and prophylactic implications. HNO. 2016;64(7):450-9. doi: https://doi.org/10.1007/s00106-016-0123-0.
Sturgis EM, Cinciripini PM. Trends in head and neck cancer incidence in relation to smoking prevalence: an emerging epidemic of human papillomavirus-associated cancers? Cancer. 2007;110(7):1429-35. doi: https://doi.org/10.1002/cncr.22963.
Marur S, D’Souza G, Westra WH, Forastiere AA. HPV-associated head and neck cancer: a virus-related cancer epidemic. Lancet Oncol. 2010;11(8):781-9. doi: https://doi.org/10.1016/S1470-2045(10)70017-6.
Hammarstedt L, Lindquist D, Dahlstrand H, Romanitan M, Dahlgren LO, Joneberg J, et al. Human papillomavirus as a risk factor for the increase in incidence of tonsillar cancer. Int J Cancer. 2006;119(11):2620-3. doi: https://doi.org/10.1002/ijc.22177.
Rietbergen MM, van Bokhoven AA, Lissenberg‐Witte BI, Heideman DAM, Leemans CR, Brakenhoff RH, et al. Epidemiologic associations of HPV‐positive oropharyngeal cancer and (pre)cancerous cervical lesions. I Jornal Cancer. 2018;143(2):283-8. doi: https://doi.org/10.1002/ijc.31315.
Ang KK, Harris J, Wheeler R, Weber R, Rosenthal DI, Nguyen-Tân PF, et al. Human papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med. 2010;363(1):24-35. doi: https://doi.org/10.1056/NEJMoa0912217.
Ndiaye C, Mena M, Alemany L, Arbyn M, Castellsagué X, Laporte L, et al. HPV DNA, E6/E7 mRNA, and p16(INK4a) detection in head and neck cancers: a systematic review and meta-analysis. Lancet Oncol. 2014;15(12):1319-31. doi: https://doi.org/10.1016/S1470-2045(14)70471-1.
Klussmann JP, Preuss SF, Speel EJ. Human papillomavirus and cancer of the oropharynx. Molecular interaction and clinical implications. HNO. 2009;57(2):113-22. doi: https://doi.org/10.1007/s00106-008-1867-y.
Figueiredo AM. Prevalências e características clínico-epidemiológicas do câncer bucal e de cabeça e pescoço no Hospital Estadual de Bauru/SP [tese]. São Paulo: Universidade de São Paulo; 2013.
Petito G, Carneiro MAS, Santos SHR, Silva AMTC, Alencar RC, Gontijo AP, et al. Human papillomavirus in oral cavity and oropharynx carcinomas in the central region of Brazil. Braz J Otorhinolaryngol. 2017;83(1):38-44. doi: https://doi.org/10.1016/j.bjorl.2016.01.004.
Caley A, Evans M, Powell N, Paleri V, Tomkinson A, Urbano TG, et al. Multicentric human papillomavirus-associated head and neck squamous cell carcinoma. Head Neck. 2015;37(2):202-8. doi: https://doi.org/10.1002/hed.23584.
Cardoso MFA, Novikoff S, Tresso A, Segreto RA, Cervantes O. Prevenção e controle das sequelas bucais em pacientes irradiados por tumores de cabeça e pescoço. Radiol Bras. 2005;38(2):107-15. doi: https://doi.org/10.1590/S0100-39842005000200006.
Graeff A, de Leeuw JR, Ros WJ, Hordijk GJ, Blijham GH, Winnubst JA. Pretreatment factors predicting quality of life after treatment for head and neck cancer. Head Neck. 2000;22(4):398-407. doi: https://doi.org/10.1002/1097-0347(200007)22:4<398::aid-hed14>3.0.co;2-v.
Chinn SB, Myers JN. Oral cavity carcinoma: current management, controversies, and future directions. J Clin Oncol. 2015;33(29):3269-76. doi: https://doi.org/10.1200/JCO.2015.61.2929.
Burd EM, Dean CL. Human papillomavirus. Microbiol Spectr. 2016;4(4). doi: 10.1128/microbiolspec.DMIH2-0001-2015.
Yeh DH, Tam S, Fung K, MacNeil SD, Yoo J, Winquist E, et al. Transoral robotic surgery vs. radiotherapy for management of oropharyngeal squamous cell carcinoma: a systematic review of the literature. Eur J Surg Oncol. 2015;41(12):1603-14. doi: https://doi.org/10.1016/j.ejso.2015.09.007.
Heijnen BJ, Speyer R, Kertscher B, Cordier R, Koetsenruijter KWJ, Swan K, et al. Dysphagia, Speech, Voice, and Trismus following Radiotherapy and/or Chemotherapy in Patients with Head and Neck Carcinoma: Review of the Literature. Biomed Res Int. 2016;2016:6086894. doi: https://doi.org/10.1155/2016/6086894.
King SN, Dunlap NE, Tennant PA, Pitts T. Pathophysiology of Radiation-Induced Dysphagia in Head and Neck Cancer. Dysphagia. 2016;31(3):339-51. doi: https://doi.org/10.1007/s00455-016-9710-1.
Connor NP, Cohen SB, Kammer RE, Sullivan PA, Brewer KA, Hong TS, et al. Impact of conventional radiotherapy on health-related quality of life and critical functions of the head and neck. Int J Radiat Oncol Biol Phys. 2006;65(4):1051-62. doi: https://doi.org/10.1016/j.ijrobp.2006.01.054.
Knox JJ, Puodziunas AL, Feld R. Chemotherary-induced oral mucositis: Prevention and management. Drugs Aging. 2000;17(4):257-67. doi: https://doi.org/10.2165/00002512-200017040-00002.
Stoeckli SJ, Guidicelli M, Schneider A, Huber A, Schmid S. Quality of life after treatment for early laryngeal carcinoma. Eur Arch Otorhinolaryngol. 2001;258(2):96-9. doi: https://doi.org/10.1007/s004050000307.
Joseph AW, Ogawa T, Bishop JA, Lyford-Pike S, Chang X, Phelps TH, et al. Molecular etiology of second primary tumors in contralateral tonsils of human papillomavirus-associated index tonsillar carcinomas. Oral Oncol. 2013;49(3):244-8. doi: https://doi.org/10.1016/j.oraloncology.2012.09.009.
Naghavi AO, Echevarria MI, Strom TJ, Abuodeh YA, Ahmed KA, Venkat PS, et al. Treatment delays, race, and outcomes in head and neck cancer. Cancer Epidemiol. 2016;45:18-25. doi: https://doi.org/10.1016/j.canep.2016.09.005
Okami K. Clinical features and treatment strategy for HPV-related oropharyngeal cancer. Int J Clin Oncol. 2016;21(5):827-35. doi: https://doi.org/10.1007/s10147-016-1009-6.
American Cancer Society. Cancer Facts & Figures 2016. Atlanta: American Cancer Society; 2016.
Downloads
Publicado
Edição
Seção
Licença
Copyright (c) 2021 Juliana Milioli Voltolini, Felipe Daniel Búrigo dos Santos
Este trabalho está licenciado sob uma licença Creative Commons Attribution-NonCommercial 4.0 International License.
Solicita-se aos autores enviar, junto com a carta aos Editores, um termo de responsabilidade. Dessa forma, os trabalhos submetidos à apreciação para publicação deverão ser acompanhados de documento de transferência de direitos autorais, contendo a assinatura de cada um dos autores, cujo modelo está a seguir apresentado:
Eu/Nós, _________________________, autor(es) do trabalho intitulado _______________, submetido agora à apreciação da Clinical and Laboratorial Research in Dentistry, concordo(amos) que os autores retém o direitos autorais e garantem a revista o direito da primeira publicação, sendo o trabalho simultaneamente autorizado sob a Creative Commons Attribution License, que permite a outros compartilhar o artigo com reconhecimento da autoria do trabalho e publicação inicial nesta Revista. Aos autores será possibilitada a distribuição em separado da versão publicada do artigo, arranjos contratuais adicionais para a distribuição não-exclusiva da versão publicada (por exemplo, publicá-la em um repositório institucional ou publicação em livro), com o reconhecimento de sua publicação inicial nesta revista. Aos autores será permitido e encorajado publicar seu trabalho on-line (por exemplo, em repositórios institucionais ou em seu site) antes e durante o processo de envio, pois pode levar a intercâmbios produtivos, bem como a maior citação do trabalho publicado. (Veja The Effect of Open Access).
Data: ____/____/____Assinatura(s): _______________
